Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Salvatore Giovanni Lanzilotta

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Cellular Oncology : the Official Journal of the International Society for Cellular Oncology|July 21, 2007
BRAF in papillary thyroid carcinomaSalvatore Giovanni Lanzilotta, Luciano Grammatica, Angelo Paradiso, et al.
Journal of the American Society of Nephrology : JASN|January 24, 2002
Increased risk of end-stage renal disease in familial IgA nephropathyFrancesco Paolo Schena, Giuseppina Cerullo, Michele Rossini, et al.
Journal of Nephrology|February 21, 2009
Genetic variant of C1GalT1 contributes to the susceptibility to IgA nephropathyDoroti Pirulli, Sergio Crovella, Sheila Ulivi, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Cellular Oncology : the Official Journal of the International Society for Cellular Oncology|July 21, 2007
BRAF in papillary thyroid carcinomaSalvatore Giovanni Lanzilotta, Luciano Grammatica, Angelo Paradiso, et al.
Journal of the American Society of Nephrology : JASN|January 24, 2002
Increased risk of end-stage renal disease in familial IgA nephropathyFrancesco Paolo Schena, Giuseppina Cerullo, Michele Rossini, et al.
Journal of Nephrology|February 21, 2009
Genetic variant of C1GalT1 contributes to the susceptibility to IgA nephropathyDoroti Pirulli, Sergio Crovella, Sheila Ulivi, et al.
Pageof 1